Analyst Tracker/Daniel Brennan

Daniel Brennan

Q: How accurate are Daniel Brennan's stock ratings?

About 69% of Daniel's ratings were profitable over a one-year hold, with an average return of +12.8% per rating, measured by 13Foresight from historical prices.

Q: How is Daniel ranked?

Daniel Brennan is ranked #830 on 13Foresight, scored on hit rate, average return versus the market, and number of calls.

TD Cowen

Wall Street Analyst

★★★★☆

#830

on 13Foresight · ranked by our own returns

69%

Success Rate

+12.4%

Average Return

78 of 113 calls profitable · +38.1% vs benchmark

Time Frame ⓘ

1 Yr 2 Yr 3 Yr 5 Yr

Compared To ⓘ

S&P 500 (SPY)

📈 Across the calls we could measure, roughly 69% of Daniel Brennan's ratings turned a profit when each position was held for 1 year — averaging +12.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

126 Buy 55 Hold 0 Sell

Daniel's Stock Coverage 42 ratings · 2026-11-10

Company	Date	Position	Consensus ⓘ	Price Target ⓘ	1-Yr Return	vs S&P 500 ⓘ
NEO NeoGenomics	Oct 29, 2026	BUY	Strong Buy +19.0% avg upside 19 analysts	$23.00 32.29% Upside	-1.8%	·
DHR Danaher	Oct 22, 2026	BUY	Strong Buy -4.4% avg upside 47 analysts	$270.00 16.28% Upside	+0.2%	·
TMO Thermo Fisher	Oct 22, 2026	BUY	Strong Buy -5.1% avg upside 40 analysts	$810.00 16.26% Upside	+2.7%	·
BDSX Biodesix	Oct 13, 2026	BUY	Strong Buy +61.4% avg upside 9 analysts	$40.00 72.07% Upside	-60.1%	·
XGN Exagen	Oct 13, 2026	BUY	Strong Buy +50.2% avg upside 11 analysts	$11.00 28.06% Upside	-1.1%	·
TXG 10x Genomics	Oct 13, 2026	HOLD	Buy -7.5% avg upside 19 analysts	$70.00 0.09% Downside	-9.4%	·
ADPT Adaptive Biotechnologies	Oct 13, 2026	BUY	Strong Buy +1.9% avg upside 17 analysts	$32.00 20.04% Upside	+15.3%	·
AVTR Avantor	Oct 13, 2026	HOLD	Buy +4.5% avg upside 27 analysts	$17.00 5.89% Upside	+0.3%	·
QTRX Quanterix	Oct 13, 2026	HOLD	Buy +548.5% avg upside 8 analysts	$3.50 20.52% Upside	-8.1%	·
NTRA Natera	Oct 13, 2026	BUY	Strong Buy -13.3% avg upside 28 analysts	$480.00 15.84% Upside	-20.8%	·
WAT Waters	Oct 13, 2026	BUY	Strong Buy -12.6% avg upside 31 analysts	$515.00 11.39% Upside	+6.6%	·
RVTY Revvity	Oct 13, 2026	BUY	Buy -19.9% avg upside 25 analysts	$175.00 11.54% Upside	+0.1%	·
MYGN Myriad Genetics	Oct 13, 2026	HOLD	Sell +159.8% avg upside 24 analysts	$4.50 29.19% Downside	+45.1%	·
ILMN Illumina	Oct 13, 2026	HOLD	Buy -10.1% avg upside 32 analysts	$270.00 14.38% Upside	-21.0%	·
A Agilent	Oct 13, 2026	BUY	Strong Buy -8.1% avg upside 35 analysts	$196.00 11.99% Upside	+3.7%	·
BRKR Bruker	Oct 13, 2026	HOLD	Buy +4.9% avg upside 22 analysts	$62.00 8.62% Upside	+18.4%	·
CAI Caris Life Sciences, Inc.	Oct 13, 2026	BUY	Strong Buy -9.5% avg upside 21 analysts	$36.00 4.89% Upside	-14.9%	·
GRAL GRAIL Inc	Oct 13, 2026	BUY	Strong Buy -18.5% avg upside 9 analysts	$180.00 25.49% Upside	-8.2%	·
FRNM Freenome Inc	Aug 18, 2026	BUY	Strong Buy +44.2% avg upside 4 analysts	$17.00 36.18% Upside	-22.2%	·
MDXH MDxHealth	Aug 13, 2026	BUY	Buy +3860.3% avg upside 9 analysts	$1.00 512.46% Upside	-66.0%	·
SERA Sera Prognostics	Aug 12, 2026	BUY	Strong Buy +265.2% avg upside 8 analysts	—	+8.4%	·
PACB Pacific Biosciences	Aug 06, 2026	BUY	Buy +73.8% avg upside 14 analysts	$3.00 15.15% Upside	+101.7%	·
SOPH SOPHiA GENETICS	Aug 04, 2026	BUY	Strong Buy +36.9% avg upside 8 analysts	—	+4.0%	·
GH Guardant Health	Jul 31, 2026	BUY	Strong Buy -3.1% avg upside 33 analysts	$210.00 17.49% Upside	-3.6%	·
WGS GeneDx Holdings	Jul 15, 2026	BUY	Strong Buy +22.6% avg upside 10 analysts	$85.00 23.10% Upside	-0.9%	·
PSNL Personalis	Jul 15, 2026	BUY	Buy -6.1% avg upside 11 analysts	$18.00 13.74% Upside	+1.0%	·
QGEN Qiagen	Jul 15, 2026	HOLD	Buy -10.5% avg upside 25 analysts	$44.00 12.29% Downside	+22.6%	·
ALMR Alamar Biosciences, Inc.	Jul 15, 2026	BUY	Strong Buy +9.2% avg upside 5 analysts	$34.00 11.19% Upside	+7.3%	·
TEM Tempus AI, Inc. Class A	Jul 15, 2026	BUY	Buy -0.2% avg upside 25 analysts	$71.00 1.65% Downside	+42.2%	·
NAUT Nautilus Biotechnolgy	Apr 28, 2026	BUY	Strong Buy +321.3% avg upside 5 analysts	—	-8.1%	·
SEER Seer	Feb 26, 2026	BUY	Strong Buy +561.3% avg upside 5 analysts	—	-19.2%	·
BDX Becton Dickinson	Jul 14, 2025	HOLD	Buy -0.4% avg upside 25 analysts	$183.00 7.51% Downside	+10.9%	·
LAB Standard BioTools	May 06, 2025	BUY	Buy +910.0% avg upside 8 analysts	$2.50 309.92% Upside	-8.5%	·
LULU Lululemon Athletica	Apr 27, 2023	BUY	Buy +62.6% avg upside 48 analysts	$525.00 389.51% Upside	-3.5%	·
VZ Verizon	Apr 26, 2023	BUY	Buy +12.2% avg upside 41 analysts	$45.00 0.67% Upside	+15.5%	·
MRVI Maravai Lifesciences Holdings	Oct 15, 2021	BUY	Strong Buy +99.5% avg upside 18 analysts	$62.00 693.90% Upside	-48.0%	·
TWST Twist Bioscience	Oct 14, 2021	BUY	Strong Buy -19.1% avg upside 16 analysts	—	-75.0%	·
CRL Charles River Labs	Aug 17, 2021	BUY	Strong Buy -28.5% avg upside 36 analysts	$465.00 29.43% Upside	-47.3%	·
MTD Mettler-Toledo	May 07, 2021	SELL	Hold -26.0% avg upside 19 analysts	$1139.00 32.00% Downside	-2.9%	·
IQV IQVIA Holdings	Apr 23, 2021	BUY	Strong Buy -2.5% avg upside 40 analysts	$275.00 2.95% Upside	-1.8%	·
ICLR Icon	Mar 01, 2021	BUY	Strong Buy -1.8% avg upside 28 analysts	$232.00 9.75% Upside	+33.7%	·
VCYT Veracyte	Nov 26, 2013	BUY	Strong Buy +4.5% avg upside 19 analysts	$16.00 68.04% Downside	-48.4%	·

🔒 37 more ratings — with price targets, crowd consensus and our measured returns.

Free account unlocks every analyst's full coverage table.

Daniel Brennan — Frequently Asked Questions

How accurate are Daniel Brennan's stock ratings?

Based on the calls 13Foresight could measure, about 69% of Daniel's ratings were profitable over a one-year hold, with an average return of +12.8% per rating, or +38.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.

How is Daniel ranked on 13Foresight?

Daniel Brennan is currently ranked #830 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.

Which stocks does Daniel cover?

Daniel most recently has ratings on NEO, DHR, TMO, BDSX, XGN, TXG, ADPT, AVTR, QTRX, NTRA, WAT, RVTY and 30 more. See the full coverage table above for positions, price targets and our measured returns.

Where can I see other analyst ratings?

Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.

Daniel Brennan

Rating Distribution

Welcome to 13Foresight!